NDC 43975-281 – Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate

Amphetamine Sulfate 6.25 mg/1; Amphetamine Dl-aspartate Monohydrate 6.25 mg/1; Dextroamphetamine Sulfate 6.25 mg/1; Dextroamphetamine Saccharate 6.25 mg/1 · Capsule, Extended Release · Oral

Human Prescription Drug DEA schedule CII 6 recalls

Product NDC43975-281

Product details

Brand name
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Generic name
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Labeler
ANI Pharmaceuticals, Inc.
Dosage form
Capsule, Extended Release
Route
Oral
Marketing category
ANDA · ANDA205401
Marketed since
March 16, 2020
Listing expires
December 31, 2027
Pharmacologic class
Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant

Active ingredients

Uses, dosage, side effects and warnings for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate →

Package NDC codes (1)

Package NDCDescriptionSince
43975-281-10100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (43975-281-10)Mar 16, 2020

Recalls mentioning this NDC

Other Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate products